Form 4 for RVMD Revolution Medicines, Inc.
Accepted 2024-11-05 00:00:00 ET · period of report 2024-11-01 · accession 0001610717-24-000517 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2024-11-05 | 2024-11-01+ | RVMD | GOLDSMITH MARK A | See Remarks, Dir | M - OptEx | $2.73 | +96.6K | 309.3K | +45% | +$263.3K |
| DMT | 2024-11-05 | 2024-11-01+ | RVMD | GOLDSMITH MARK A | See Remarks, Dir | S - Sale+OE | $55.48 | -60.0K | 300.2K | -17% | -$3.33M |
| DMTI | 2024-11-05 | 2024-11-01 | RVMD | GOLDSMITH MARK A | See Remarks, Dir | S - Sale+OE | $55.02 | -10.0K | 20.4K | -33% | -$550.2K |
| DMT | 2024-11-05 | 2024-11-01+ | RVMD | GOLDSMITH MARK A | See Remarks, Dir | M - OptEx | $0.00 | -96.6K | 232.1K | -29% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-11-04 | M | A | 36,600 | $0.49 | 336,770 | D | — | — | (F2) Includes 188,750 restricted stock units. |
| 2 | Common | Common Stock | 2024-11-04 | S | D | 50,900 | $55.56 | 300,170 | D | — | — | (F8) This transaction was executed in multiple trades in prices ranging from $55.00 to $55.87, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. (F2) Includes 188,750 restricted stock units. |
| 3 | Common | Common Stock | 2024-11-04 | M | A | 50,900 | $4.09 | 351,070 | D | — | — | (F2) Includes 188,750 restricted stock units. |
| 4 | Common | Common Stock | 2024-11-01 | S | D | 5,000 | $55.02 | 20,424 | I | — | — | (F4) This transaction was executed in multiple trades in prices ranging from $55.00 to $55.15, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| 5 | Common | Common Stock | 2024-11-01 | S | D | 9,100 | $55.02 | 300,170 | D Trust | — | — | (F3) This transaction was executed in multiple trades in prices ranging from $55.00 to $55.17, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. (F2) Includes 188,750 restricted stock units. (F6) Held by Rebecca Eve Goldsmith Trust under the Goldsmith Children's 2011 Irrevocable Education Trust, dated December 15, 2011. |
| 6 | Common | Common Stock | 2024-11-01 | M | A | 9,100 | $4.09 | 309,270 | D Trust | — | — | (F2) Includes 188,750 restricted stock units. (F5) Held by Jonathan Goldsmith Revocable Trust. |
| 7 | Common | Common Stock | 2024-11-01 | S | D | 5,000 | $55.03 | 20,424 | I | — | — | (F4) This transaction was executed in multiple trades in prices ranging from $55.00 to $55.15, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| 8 | Derivative | Stock Option (Right to Buy) | 2024-11-04 | M | D | 36,600 | $0.00 | 30,846 | D | $0.49 · 2020-12-01 to 2027-03-20 | 36,600 Common Stock | |
| 9 | Derivative | Stock Option (Right to Buy) | 2024-11-04 | M | D | 50,900 | $0.00 | 181,229 | D | $4.09 · 2023-03-13 to 2029-03-12 | 50,900 Common Stock | |
| 10 | Derivative | Stock Option (Right to Buy) | 2024-11-01 | M | D | 9,100 | $0.00 | 232,129 | D | $4.09 · 2023-03-13 to 2029-03-12 | 9,100 Common Stock |